CUV clinuvel pharmaceuticals limited

who can afford afamelanotide?, page-6

  1. 108 Posts.
    The pricepoint will not be carved in stone on mount sinai.

    Upon initial approval for EPP and only administered to a small population, the price will be high, in the interest of maximizing profits.

    As other indications gain approval, the price, we can reasonably expect, will drop in conjunction with the growing base of consumers. This is all in the best interest of the company and its shareholders.

    We can criticize management for being too cautious, but we have to also be clear about the risks they would have been taking on our behalf if they had been more aggressive. If the IND had been disapproved, what would the SP be today? The SP fell slightly after IND approval. It would surely have gone below $.10 with a disapproval.

    They've been conservative, maybe overcautious. But the result has been that 90% of announcements are completely positive.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.25
Change
0.490(4.17%)
Mkt cap ! $614.0M
Open High Low Value Volume
$11.80 $12.32 $11.79 $1.611M 133.0K

Buyers (Bids)

No. Vol. Price($)
1 600 $12.12
 

Sellers (Offers)

Price($) Vol. No.
$12.25 390 1
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.